Panu Wongcha-um
Senior Correspondent at Reuters
Senior Correspondent for @Reuters based in Thailand. President of the Foreign Correspondents’ Club of Thailand (@FCCThai). Retweets are not endorsements.
Articles
-
2 weeks ago |
msn.com | Panu Wongcha-um
Microsoft Cares About Your PrivacyMicrosoft and our third-party vendors use cookies to store and access information such as unique IDs to deliver, maintain and improve our services and ads. If you agree, MSN and Microsoft Bing will personalise the content and ads that you see. You can select ‘I Accept’ to consent to these uses or click on ‘Manage preferences’ to review your options and exercise your right to object to Legitimate Interest where used.
-
2 weeks ago |
kfgo.com | Panu Wongcha-um
By Panu Wongcha-umBANGKOK (Reuters) -Thailand will advocate more international engagement with Myanmar at an upcoming Southeast Asia leader summit next week, its foreign minister said, in a push for international cooperation to broaden a diplomatic effort to end a protracted civil war.
-
2 weeks ago |
reuters.com | Panu Wongcha-um |Danial Azhar |Devjyot Ghoshal
BANGKOK/KUALA LUMPUR, May 22 (Reuters) - Separate talks with Myanmar's junta leader and his key rivals have borne fruit, Malaysia's Prime Minister Anwar Ibrahim said, setting the stage for the first time for direct contact between two sides embroiled in a protracted and devastating civil war.
-
1 month ago |
dagenspharma.dk | Panu Wongcha-um |Emelia Sithole-Matarise
Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024. REUTERS/Hollie Adams/File Photo BANGKOK, April 28 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab has launched its hugely popular weight-loss drug Wegovy in Thailand, an executive of the Danish drugmaker's local subsidiary said on Monday, marking the injectable drug's first entry into the Southeast Asian market.
-
1 month ago |
bilyonaryo.com | Panu Wongcha-um
SOURCE: ReutersBy Panu Wongcha-umBANGKOK, April 28 (Reuters) – Novo Nordisk NOVOb.CO has launched its hugely popular weight-loss drug Wegovy in Thailand, an executive of the Danish drugmaker’s local subsidiary said on Monday, marking the injectable drug’s first entry into the Southeast Asian market. First launched in 2021, Wegovy helped make Novo Nordisk Europe’s most valuable listed company until recently, worth $615 billion at its peak.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →Coverage map
X (formerly Twitter)
- Followers
- 10K
- Tweets
- 73K
- DMs Open
- No
RT @Reaproy: Happening today (13 May) at the @FCCThai at 2 pm - panel discussion on rethinking the global order in the age of American retr…
RT @IrrawaddyNews: The Karen National Union and its allies seize the border trade hub of Hteekhee after the fall of the junta’s last base o…
RT @Standard_Wealth: BREAKING: กระทรวงการคลัง ประกาศวันยื่นใบสมัคร ‘ผู้ว่าฯ แบงก์ชาติ’ แค่ 23 วันเท่านั้น! ตั้งแต่ 13 พฤษภาคม - 4 มิถุนายน…